Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Roivant Has In-licensed Rights to Moscliciguat from Bayer (2024-09-10)
> Mosliciguat, a potential first-in-class and best-in-category inhaled soluble Guanylate Cyclase (sGC) activator with targeted delivery to the lungs and once-daily administration, is being developed for pulmonary hypertension associated with interstitial lung disea...
Agronomics: Formo Bio GmbH Closes $61m Series B Round (2024-09-10)
Agronomics (LSE: ANIC), a leading listed company in the field of cellular agriculture, is pleased to report that portfolio company Formo Bio GmbH ("Formo") has announced it secured US$ 61 million in its Series B funding round. The funding round included existing...
Oxford Nanopore Sues BGI/MGI for Breach of Contract (2024-09-10)
Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore" or "the Group"), the company delivering a new generation of nanopore-based molecular sensing technology, today announces that it has filed an ex parte application under 28 U.S.C. § 1782 in the U.S. Dis...
NanoSyrinx Closes £10m Round & Appoints Edwin Moses as Chair (2024-09-10)
> Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind > Appointment of Edwin Moses as Chairman to support the leadership team in maximising the val...
Tempus Announces Real World Data Collaboration with BioNTech (2024-09-04)
The strategic collaboration will leverage Tempus’ large multimodal datasets to enhance BioNTech’s next-generation oncology pipeline Tempus AI, Inc. (NASDAQ: TEM, “Tempus”), a technology company leading the adoption of AI to advance precision medicine a...
Mainz Biomed Expands Collaboration with Liquid Biosciences (2024-09-04)
PancAlert is a Next-Generation Pancreatic Cancer Detection Test in Mainz Biomed’s Research and Development Pipeline – Promising Results of First Analysis Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagno...
Haya Therapeutics and Lilly: >$1b Multi-year Collaboration (2024-09-04)
HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics for chronic diseases, today announced a multi-year agreement with Eli Lilly and Company to apply HAYA’s advanced RNA-guided regulatory genome p...
Vignette Bio Licenses Ab from EpimAb Outside Greater China (2024-09-04)
EpimAb Biotherapeutics, Inc. ("EpimAb" or "EpimAb Biotherapeutics") a clinical stage biopharmaceutical company specializing in the discovery and development of multi-specific antibodies for diseases with high unmet need, and Vignette Bio, Inc. ("Vignette" or "Vigne...
Azenta Appoints John P. Marotta as CEO (2024-09-04)
Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz wil...
Boehringer Ingelheim Acquires Saiba Animal Health AG (2024-09-03)
Boehringer Ingelheim today said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. With the acquisition, Boehringer Ingelheim strengthens its animal health research and...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]